[rxsid]

April 23 (Reuters) - Gilead Sciences Inc(GILD):

* GILEAD SCIENCES SAYS "REGRET THAT THE WHO PREMATURELY POSTED" INFORMATION REGARDING ANTIVIRAL DRUG REMDESIVIR STUDY, WHICH HAS SINCE BEEN REMOVED

* GILEAD SAYS INVESTIGATORS IN REMDESIVIR STUDY DID NOT PROVIDE PERMISSION FOR PUBLICATION OF RESULTS

[mmichaels1970]

Here's a link.

“We regret that the WHO prematurely posted information regarding the study, which has since been removed. The investigators in this study did not provide permission for publication of results,” a Gilead spokesperson said in a statement to CNBC.

“Furthermore, we believe the post included inappropriate characterizations of the study. Importantly, because this study was terminated early due to low enrollment, it was underpowered to enable statistically meaningful conclusions,” according to Gilead. “As such, the study results are inconclusive, though trends in the data suggest a potential benefit for remdesivir, particularly among patients treated early in disease.”